4//SEC Filing
LANCHBURY JERRY S 4
Accession 0001219036-21-000024
CIK 0000899923other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 8:32 PM ET
Size
17.8 KB
Accession
0001219036-21-000024
Insider Transaction Report
Form 4
LANCHBURY JERRY S
Executive V.P. - Research
Transactions
- Exercise/Conversion
Common Stock
2021-08-23$27.07/sh+40,000$1,082,800→ 272,550 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-08-23−10,000→ 70,000 totalExercise: $27.07Exp: 2022-09-12→ Common Stock (10,000 underlying) - Sale
Common Stock
2021-08-23$35.07/sh−40,000$1,402,800→ 232,550 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-08-24−30,000→ 0 totalExercise: $27.07Exp: 2022-09-12→ Common Stock (30,000 underlying) - Exercise/Conversion
Common Stock
2021-08-23$27.07/sh+10,000$270,700→ 242,550 total - Exercise/Conversion
Common Stock
2021-08-24$27.07/sh+30,000$812,100→ 262,550 total - Sale
Common Stock
2021-08-23$35.57/sh−10,000$355,700→ 232,550 total - Sale
Common Stock
2021-08-24$35.57/sh−30,000$1,067,100→ 232,550 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-08-23−40,000→ 30,000 totalExercise: $27.07Exp: 2022-09-12→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The shares subject to this option are fully vested and exercisable.
Documents
Issuer
MYRIAD GENETICS INC
CIK 0000899923
Entity typeother
Related Parties
1- filerCIK 0001219036
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 8:32 PM ET
- Size
- 17.8 KB